Sonoma Pharmaceuticals Filing Effectiveness Notice
Ticker: SNOA · Form: EFFECT · Filed: Apr 24, 2026 · CIK: 0001367083
Sentiment: neutral
Topics: registration-statement, effectiveness, filing-notice
TL;DR
Sonoma Pharma's registration statement is now effective. Big news coming?
AI Summary
Sonoma Pharmaceuticals, Inc. filed an EFFECT form on April 24, 2026, indicating the effectiveness of a registration statement. The filing, with SEC Accession No. 9999999995-26-001319, relates to Act 33 and File No. 333-295171. The company's business address is 5445 Conestoga Court, Suite 150, Boulder, CO 80301.
Why It Matters
This filing signifies that a registration statement for Sonoma Pharmaceuticals, Inc. has become effective, potentially paving the way for new securities offerings or other regulatory actions.
Risk Assessment
Risk Level: low — This is a procedural filing indicating the effectiveness of a registration statement, not a direct financial event.
Key Numbers
- 2026-04-24 — Filing Acceptance Date (Date the EFFECT filing was accepted by the SEC.)
- 2026-04-23 — Effectiveness Date (The date the registration statement became effective.)
Key Players & Entities
- Sonoma Pharmaceuticals, Inc. (company) — Filer
- 9999999995-26-001319 (dollar_amount) — SEC Accession Number
- 333-295171 (dollar_amount) — File Number
- 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 (company) — Mailing and Business Address
FAQ
What type of registration statement has become effective for Sonoma Pharmaceuticals, Inc.?
The filing is a Form EFFECT, which is a Notice of Effectiveness, indicating a registration statement has become effective.
What is the SEC Accession Number for this filing?
The SEC Accession Number is 9999999995-26-001319.
When was this filing accepted by the SEC?
The filing was accepted on April 24, 2026.
What is Sonoma Pharmaceuticals, Inc.'s business address?
The business address is 5445 Conestoga Court, Suite 150, Boulder, CO 80301.
What is the File Number associated with this registration statement?
The File Number is 333-295171.
Filing Details
This Form EFFECT (Form EFFECT) was filed with the SEC on April 24, 2026 regarding Sonoma Pharmaceuticals, Inc. (SNOA).